FDA issues new antidepressant warnings

The U.S. Food and Drug Administration proposed that the labels of all antidepressant medications warn of increased risks of suicidal thoughts and behavior for young adults, ages 18 to 24.

Here is the complete list:

Desyrel (trazodone HCl)

Elavil (amitriptyline)

Effexor (venlafaxine HCl)

Emsam (selegiline)

Etrafon (perphenazine/amitriptyline)

fluvoxamine maleate

Lexapro (escitalopram hydrobromide)

Limbitrol (chlordiazepoxide/amitriptyline)

Ludiomil (maprotiline)

Marplan (isocarboxazid)

Nardil (phenelzine sulfate)

nefazodone HCl

Norpramin (desipramine HCl)

Pamelor (nortriptyline)

Parnate (tranylcypromine sulfate)

Paxil (paroxetine HCl)

Pexeva (paroxetine mesylate)

Prozac (fluoxetine HCl)

Remeron (mirtazapine)

Sarafem (fluoxetine HCl)

Seroquel (quetiapine)

Sinequan (doxepin)

Surmontil (trimipramine)

Symbyax (olanzapine/fluoxetine)

Tofranil (imipramine)

Tofranil-PM (imipramine pamoate)

Triavil (perphenazine/amitriptyline)

Vivactil (protriptyline)

Wellbutrin (bupropion HCl)

Zoloft (sertraline HCl)

Zyban (bupropion HCl)

Source: Food and Drug Administration

MORE FROM MENTAL HEALTH

Mental health Section Front

Teen Internet addicts more likely to self harm Dark shadows loom over ‘facilitated’ talk Compulsive hoarders suddenly in the spotlight Early treatment may help kids with autism Military experiment seeks to predict PTSD Army helps vets with ‘invisible wounds’ get jobs Army suicides to top 2008, but progress seen Suicides raise worries about recession’s real cost Chill: A little stress may help you live longer Suicide prevention groups protest ‘The Office’ Mental health Section Front   Add Mental health headlines to your news reader: